Efectividad de la Sputnik. Importante trabajo de casos y controles, 13.894 pacientes, infectados, variante delta. Se calculó la efectividad de la Sputnik V (1/) https://t.co/sxziL18UNs
Glad to see this study from SPb, Russia: 81% effectiveness of Sputnik against referral to hospital, 76% against severe lung damage. Vaccine Effectiveness against Referral to Hospital and Severe… https://t.co/e3gBreUlIw
Our study on the real-world effectiveness of Sputnik vaccine against COVID-19 hospitalization in infected persons. Disease attenuation is important goal of the vaccination along with disease prevention. https://t.co/vtc7WSWDGR https://t.co/esyARnvZVd
RT @TsioutisC: Sputnik V Vaccine Effectiveness against Referral to Hospital & Severe Lung Injury Associated: Population-Based Case-Control…
“the adjusted VE against referral to hospital was 81% (95% CI: 68–88) for complete vaccination.” “The effect of the partial vaccination was not statistically significant.”
Sputnik V Vaccine Effectiveness against Referral to Hospital & Severe Lung Injury Associated: Population-Based Case-Control Study in St. Petersburg, Russia https://t.co/PkP9H7cK58 https://t.co/hrJ2pmqKvA
RT @ABsteward: The first study "preprint" about Sputnik V vaccine effectiveness /presumed Delta protection ! Vaccine Effectiveness against…
RT @hguclu: Rusya'da 14 bin kişi üzerinde yapılan çalışma sonucuna göre (henüz önyayın) Rusya'nın Sputnik V aşısı delta varyantı enfeksiyon…
The first study "preprint" about Sputnik V vaccine effectiveness /presumed Delta protection ! Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19:A Population-Based Case-Control Study in St. Petersburg, Russia
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-based Case-control Study in St. Petersburg, Russia https://t.co/C4X7HTZ82Q
RT @hguclu: Rusya'da 14 bin kişi üzerinde yapılan çalışma sonucuna göre (henüz önyayın) Rusya'nın Sputnik V aşısı delta varyantı enfeksiyon…
Rusya'da 14 bin kişi üzerinde yapılan çalışma sonucuna göre (henüz önyayın) Rusya'nın Sputnik V aşısı delta varyantı enfeksiyonunda ağır hastalığı %81 engelliyor. https://t.co/93cbAz92JP https://t.co/somyJQ1vbR
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-based Case-control Study in St. Petersburg, Russia https://t.co/hYpfEk8mpG
RT @AntonBarchuk: Our new preprint is out. It’s a first study examining the real-world effectiveness of COVID-19 vaccination with Sputnik V…
RT @jtwigg9: New pre-print (not yet peer reviewed) with real-world data showing strong protection against hospitalization for Russia's covi…
RT @hildabast: Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495…
RT @AntonBarchuk: Our new preprint is out. It’s a first study examining the real-world effectiveness of COVID-19 vaccination with Sputnik V…
Our new preprint is out. It’s a first study examining the real-world effectiveness of COVID-19 vaccination with Sputnik V in Russia. It shows that vaccination significantly diminishes disease severity and protects the lungs from virus-induced injury. https
RT @jtwigg9: New pre-print (not yet peer reviewed) with real-world data showing strong protection against hospitalization for Russia's covi…
New pre-print (not yet peer reviewed) with real-world data showing strong protection against hospitalization for Russia's covid vaccines (mostly Sputnik V). This looks like a solid study, and—unlike previous Sputnik V assessments—the raw data's on GitHub.
RT @PabloRichly: "The effect of the partial vaccination against referral to hospital was 35% (95% CI: 21–65)." Para Delta no alcanzaria sol…
"The effect of the partial vaccination against referral to hospital was 35% (95% CI: 21–65)." Para Delta no alcanzaria solo con el componente 1 (Sputnik Light). https://t.co/tXCOGotJRS
@Mars2545 @14ttir @SaiSeeMaP @noname_8 @moui @kalanistan @DonghuaDijun28 @Unrulycat2511 @bombanoi @wirojlak @iamasiam14 @CKA_AY @cm_mcv @victorworldfilm @Thai_Talk @sleeplessbkk @k0b_k0b ข้ามมาดูงานวิจัยฝั่งรัสเซียกันบ้างกับประสิทธิภาพป้องกันการแอดมิทเข้าโ
RT @hildabast: Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495…
Bene Sputnik
RT @hildabast: Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495…
RT @hildabast: Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495…
RT @hildabast: Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495…
Sputnik V's vax effectiveness against Delta: two doses are 81% against hospitalization, one dose is ineffective. Against severe disease (presuming >25% lung injury), it's ~70%. It's not excellent, but it definitely is good enough. H/T @hildabast https
RT @hildabast: Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495…
RT @hildabast: Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495…
RT @hildabast: Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495…
badania nad Sputnikiem
Unmatched case-control study from Russia, Sputnik V: 13,895 people with Covid-19 triaged during Delta outbreak, of whom 495 were hospitalized. About 19% of people in the community had 2 doses of vax: 10% of those triaged had 2 doses...1/2 https://t.co/d3Jk
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-based Case-control Study in St. Petersburg, Russia https://t.co/rBtJCq6Gni"
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-based Case-control Study in St. Petersburg, Russia https://t.co/tsycRXUoBa #medRxiv